Year: 2025

JPMorgan, Citi, Morgan Stanley client data may be exposed by vendor’s hack, NYT reports

• Uncategorized

JPMorgan, Citi, Morgan Stanley client data may be exposed by vendor’s hack, NYT reports

Bull Bear Daily November 23, 2025 0

(Reuters) -Client data for JPMorgan Chase, Citi, Morgan Stanley and other major banks may have been accessed...

Read More Read more about JPMorgan, Citi, Morgan Stanley client data may be exposed by vendor’s hack, NYT reports

No recession risk for US economy as a whole after $11 billion shutdown hit, Bessent says

• Uncategorized

No recession risk for US economy as a whole after $11 billion shutdown hit, Bessent says

Bull Bear Daily November 23, 2025 0

By Andrea Shalal and David Lawder WASHINGTON (Reuters) -Treasury Secretary Scott Bessent on Sunday said the 43-day...

Read More Read more about No recession risk for US economy as a whole after $11 billion shutdown hit, Bessent says

New York police commissioner credited with crime drop to stay on under Mamdani

• Uncategorized

New York police commissioner credited with crime drop to stay on under Mamdani

Bull Bear Daily November 23, 2025 0

By Jonathan Allen and Maria Tsvetkova NEW YORK (Reuters) -Jessica Tisch, the New York City police commissioner...

Read More Read more about New York police commissioner credited with crime drop to stay on under Mamdani

Lawmakers urge US to enforce Biden wheelchair air travel rules

• Newsletters

Lawmakers urge US to enforce Biden wheelchair air travel rules

Bull Bear Daily November 23, 2025 0

By David Shepardson WASHINGTON (Reuters) -A group of U.S. House lawmakers on Friday called on the Trump...

Read More Read more about Lawmakers urge US to enforce Biden wheelchair air travel rules

US FDA investigates Takeda’s blood disorder drug after pediatric death

• Newsletters

US FDA investigates Takeda’s blood disorder drug after pediatric death

Bull Bear Daily November 23, 2025 0

(Reuters) -The U.S. Food and Drug Administration said on Friday it is investigating the death of a...

Read More Read more about US FDA investigates Takeda’s blood disorder drug after pediatric death

New Orleans is the next target of Trump immigration crackdown, sources say

• Newsletters

New Orleans is the next target of Trump immigration crackdown, sources say

Bull Bear Daily November 22, 2025 0

Trump’s Exec Order #14154 – A “Millionaire-Maker” In Today’s News New 0DTE Hack Beats Wall Street at...

Read More Read more about New Orleans is the next target of Trump immigration crackdown, sources say

Fed’s Collins: Monetary policy currently in right place, hesitant about cutting rates

• Uncategorized

Fed’s Collins: Monetary policy currently in right place, hesitant about cutting rates

Bull Bear Daily November 22, 2025 0

By Michael S. Derby BOSTON (Reuters) -Federal Reserve Bank of Boston President Susan Collins said Saturday that...

Read More Read more about Fed’s Collins: Monetary policy currently in right place, hesitant about cutting rates

New Orleans is the next target of Trump immigration crackdown, sources say

• Uncategorized

New Orleans is the next target of Trump immigration crackdown, sources say

Bull Bear Daily November 22, 2025 0

By Ted Hesson WASHINGTON (Reuters) -President Donald Trump’s administration intends to focus on New Orleans in the...

Read More Read more about New Orleans is the next target of Trump immigration crackdown, sources say

Airbus signs 150-jet deal with flydubai worth $24 billion

• Uncategorized

Airbus signs 150-jet deal with flydubai worth $24 billion

Bull Bear Daily November 22, 2025 0

By Ahmed Elimam, Federico Maccioni and Tim Hepher (Reuters) -Airbus won a provisional order for 150 A321neo...

Read More Read more about Airbus signs 150-jet deal with flydubai worth $24 billion

Researchers move closer to matching patients with GLP-1 drug that works best for them

• Uncategorized

Researchers move closer to matching patients with GLP-1 drug that works best for them

Bull Bear Daily November 22, 2025 0

By Nancy Lapid (Reuters) -U.S. researchers are beginning to identify clinical characteristics that distinguish “super responders” to...

Read More Read more about Researchers move closer to matching patients with GLP-1 drug that works best for them